Normalizing Metabolism in Diabetic Pregnancy: Is It Time to Target Lipids?
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Outcomes in pregnancies complicated by preexisting diabetes (type 1 and type 2) and gestational diabetes mellitus have improved, but there is still excess morbidity compared with normal pregnancy. Management strategies appropriately focus on maternal glycemia, which demonstrably improves pregnancy outcomes for mother and infant. However, we may be reaching the boundaries of obtainable glycemic control for many women. It has been acknowledged that maternal lipids are important in pregnancies complicated by diabetes. Elevated maternal lipids are associated with preeclampsia, preterm delivery, and large-for-gestational-age infants. Despite this understanding, assessment of management strategies targeting maternal lipids has been neglected to date. Consideration needs to be given to whether normalizing maternal lipids would further improve pregnancy outcomes. This review examines the dyslipidemia associated with pregnancy complicated by diabetes, reviews possible therapies, and considers whether it is time to start actively managing this aspect of maternal metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schaefer-Graf, U. M., Graf, K., Kulbacka, I., Kjos, S. L., Dudenhausen, J., Vetter, K., & Herrera, E. (2008) · Diabetes Care · doi:10.2337/dc08-0039 · Cited by 439 · cited 6×
“Infants born LGA have an increased fat mass (29).”
BackgroundInfluentialSevere hypertriglyceridemia in pregnancy
Goldberg, A. S., & Hegele, R. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1250 · Cited by 187 · cited 6×
“Niacin (Vitamin B3, Nicotinic Acid) Niacin use in pregnancy has been reported in case reports only, and pharmacological doses are considerably higher than the recommended daily intake (34).”
BackgroundInfluentialReview: Transport of maternal cholesterol to the fetal circulation
Woollett, L. A. (2011) · Placenta · doi:10.1016/j.placenta.2011.01.011 · Cited by 173
Patterns of Glycemia in Normal Pregnancy
Hernandez, T. L., Friedman, J. E., Van Pelt, R. E., & Barbour, L. A. (2011) · Diabetes Care · doi:10.2337/dc11-0241 · Cited by 170
Hypocaloric diets and ketogenesis in the management of obese gestational diabetic women
Knopp, R. H., Magee, M. S., Raisys, V, Benedetti, T., & Bonet, B. (1991) · Journal of the American College of Nutrition · doi:10.1080/07315724.1991.10718184 · Cited by 97 · cited 1×
“The use of a hypocaloric diet (without changing proportions of carbohydrate/fat/protein) in comparisonwith subcutaneous insulin therapy over 1 week in obese women with GDM reduced maternal triglycerides (39).”
BackgroundPlacental fatty acid transport in maternal obesity
Cetin, I., Parisi, F., Berti, C., Mandò, C., & Desoye, G. (2012) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174412000414 · Cited by 45
Cited by
Lifestyle interventions for the treatment of women with gestational diabetes
Brown, J., Alwan, N. A., West, J., Brown, S., McKinlay, C. J., Farrar, D., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011970.pub2 · Cited by 284
Grieger, J. A., Bianco-Miotto, T., Grzeskowiak, L. E., Leemaqz, S. Y., Poston, L., McCowan, L. M., Kenny, L. C., Myers, J. E., Walker, J. J., Dekker, G. A., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002710 · Cited by 182
Vuong, B., Odero, G., Rozbacher, S., Stevenson, M., Kereliuk, S. M., Pereira, T. J., Dolinsky, V. W., & Kauppinen, T. M. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0859-9 · Cited by 147
National lipid association annual summary of clinical lipidology 2016
Bays, H. E., Jones, P. H., Orringer, C. E., Brown, W. V., & Jacobson, T. A. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.08.002 · Cited by 128
Moyce, B. L., & Dolinsky, V. W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113467 · Cited by 128
“With the body of evidence implicating lipotoxicity in β-cell failure, approaches that reduce circulating lipids in GDM may potentiate glycemic control and improve risks of complications; however, current pharmacological therapies for hyperlipidemia and hypercholesterolemia are not widely studied in pregnancy [76].”
Background
Metadata
- Authors
- Barrett, H. L., Dekker Nitert, M., McIntyre, H. D., & Callaway, L. K.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-04-10
- Volume
- 37
- Issue
- 5
- Pages
- 1484-1493
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2130783736
- Cited by
- 150
- References
- 6
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.